How do we determine what a fair price for a life-saving prescription medication should be? This month, we discuss what is means for a price to be “fair” and explore the current legal and economic landscape of prescription drug pricing in the US.
Megan Chao Smith joins Ethics Talk to discuss their article, coauthored with Dr Shanda Demorest: “How Should Clinicians and Health Care Organizations Respond When Civic Planning Concentrates Waste Processing in Minoritized Communities?”
Genevieve S. Silva joins Ethics Talk to discuss her article, coauthored with Dr Cassandra Thiel: “What Would It Mean for Health Care Organizations to Justly Manage Their Waste?”
Dr Susan Veldheer joins Ethics Talk to discuss her article, coauthored with Dr Daniel R. George: "Strategies to Help Health Care Organizations Execute Their Food System Leadership Responsibilities.”
Debbie Berkowitz joins Ethics Talk to discuss her article, coauthored with Anna D. Goff, Dr Kathleen Marie Fagan, and Dr Monica L. Gerrek: "Do Clinics in Meat and Poultry Plants Endanger Workers?”
Dr Adam T. Perzynski joins Ethics Talk to discuss his article, coauthored with Dr Kurt C. Stange: “How Should Clinicians Ally With Patients Whose Health Is Unlikely to Be Improved by Even Numerous Clinical Encounters?”
Dr Lisa Lehmann joins Ethics Talk to discuss “grateful patient programs,” pressures clinicians face to fundraise on behalf of health care organizations for which they work, and whether “VIP” care really is better for patients.
